US2006216743A1PendingUtilityA1
Methods and systems for detecting biomolecular binding using terahertz radiation
Est. expiryAug 4, 2024(expired)· nominal 20-yr term from priority
G01N 2021/651G01N 33/54373G01N 21/3581C12Q 1/6825B01L 3/5027B01J 2219/00722B01J 2219/00639B01J 2219/00637B01J 2219/00626B01J 2219/00612B01J 2219/0061B01J 2219/00605G01N 21/7743G01N 21/65
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are methods and systems for detecting biomolecular binding events using gigahertz or terahertz radiation. The methods and systems use low-energy spectroscopy to detect biomolecular binding events between molecules in an aqueous solution. The detected biomolecular binding events include, for example, nucleic acid hybridizations, antibody/antigen binding, and receptor/ligand binding.
Claims
exact text as granted — not AI-modified1 . A method to detect an analyte in a biological sample, comprising:
a) contacting the biological sample with a first molecule immobilized on a substrate, wherein the first molecule is suspected of binding the analyte; b) impinging the first molecule with a gigahertz or terahertz input radiation; and c) detecting a vibrational spectrum of the first molecule, wherein a shift in the vibrational spectrum, or decrease in an intensity level of the vibrational spectrum, compared to a vibrational spectrum of a first molecule not associated with the analyte, is indicative of the presence of the analyte in the sample.
2 . The method of claim 1 , wherein the biological sample is from blood, urine, saliva, tissue, ejaculate, serum, cerebrospinal fluid, pleural fluid, ascites fluid, sputum, stool, or a biopsy sample.
3 . A method to identify an agent that affects a biomolecular binding, comprising:
a) contacting a first molecule, a second molecule, and the agent, wherein the first molecule binds to the second molecule; b) impinging the first molecule with a gigahertz or terahertz light source; and c) detecting a vibrational spectrum of the first molecule, wherein a shift in the vibrational spectrum or a change in intensity level of the vibrational spectrum, compared to a vibrational spectrum of a first molecule bound to the second molecule in the absence of the agent, identifies the agent that affects the molecule binding.
4 . The method of claim 3 , wherein the first molecule is a nucleic acid molecule.
5 . The method of claim 3 , wherein the first molecule is a protein.
6 . The method of claim 5 , wherein the protein is an antibody.
7 . A method of detecting a biomolecular binding event, the method comprising:
a) preparing a sample comprising a first molecule and a second molecule; b) directing an input radiation at the sample, whereby the input radiation excites the sample without causing fluorescence; and c) detecting an exit radiation traveling from the sample, wherein a shift in vibrational frequency or a change in intensity level of the exit radiation compared to the exit radiation detected for a first molecule not bound to the second molecule, is indicative of a biomolecular interaction.Join the waitlist — get patent alerts
Track US2006216743A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.